Last edition
News about "Precision Medicine"
Neuroscientist Dale E. Bredesen has proposed the Pr2 theory, a new framework that views neurodegeneration as a response to persistent biological stress and explores a precision-medicine approach to Alzheimer’s disease.
Precision Medicine | 24/08/2026 | By News Bureau
India Expands AI-Driven Biotechnology Research across Genomics, Healthcare and Biomanufacturing
The Government of India is advancing AI-driven biotechnology through GenomeIndia, Bio-AI Hubs, IBDC and medical imaging initiatives to boost precision medicine and healthcare.
Precision Medicine | 31/07/2026 | By News Bureau | 134
IMU Biosciences Partners with Waters to Advance AI Immune Mapping Platform
IMU Biosciences has selected Waters to advance its Artificial Intelligence (AI)-powered immune mapping platform, accelerating early disease diagnosis, patient monitoring, and precision medicine development.
Precision Medicine | 26/06/2026 | By News Bureau | 237
Sophia Genetics Signs MoU with Memorial Sloan Kettering Cancer Center
Sophia Genetics has signed a strategic collaboration Memorandum of Understanding (MoU) with Memorial Sloan Kettering Cancer Center to establish a next-generation precision medicine hub.
Precision Medicine | 08/06/2026 | By News Bureau | 177
Tempus Wins FDA Approval for xT CDx, Expanding Solid Tumor Testing Portfolio
Tempus has received US FDA approval for its tumor-only xT CDx, becoming the first laboratory with companion diagnostic approval for both tumor-only and tumor-normal genomic profiling.
Precision Medicine | 30/05/2026 | By News Bureau | 249
Genethon and Ampersand Biomedicines Partner to Develop Precision Gene Therapy Vectors
Genethon and Ampersand Biomedicines join forces to engineer advanced AAV gene therapy vectors designed for greater tissue specificity, potentially enabling safer and more effective treatments for patients with rare genetic disorders.
Precision Medicine | 25/05/2026 | By News Bureau | 132
Dr. Jitendra Singh Launches UMMID Program, Highlights Future of Genomic and Precision Medicine
Dr. Jitendra Singh dedicates the UMMID Program to the nation, highlighting the growing role of genomic and precision medicine in advancing early intervention, personalised treatment, and affordable healthcare for rare genetic disorders in India.
Precision Medicine | 22/05/2026 | By News Bureau | 195
Thryv Therapeutics Advances THRV-1268 Programme with Phase II/III Trial and FDA Fast Track Status
Thryv Therapeutics initiates Phase II/III clinical testing and secures FDA Fast Track status for THRV-1268, advancing a potential first-in-class therapy for Long QT Syndrome.
Precision Medicine | 27/04/2026 | By News Bureau | 181
GlycoNex Secures PMDA Nod for First-in-Human Trial of Cancer Drug GNX1021
Japan’s Pharmaceuticals and Medical Devices Agency approves Phase I clinical trial of GlycoNex’s novel antibody-drug conjugate targeting gastrointestinal cancers.
Precision Medicine | 16/04/2026 | By News Bureau | 330
PrecisionLife and Ovation Partner to Launch GLP-1 stratification LDT and GLP-1 DNA Test in H2 2026
PrecisionLife and Ovation partner to launch GLP-1 stratification LDT and consumer DNA test in 2026, with early data showing distinct genetic markers for weight loss and glycemic control.
Precision Medicine | 16/04/2026 | By News Bureau | 132
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy